Physician characteristics, industry transfers, and pharmaceutical prescribing: Empirical evidence from medicare and the physician payment sunshine act-Reference-Cited by-同舟云学术

Physician characteristics, industry transfers, and pharmaceutical prescribing: Empirical evidence from medicare and the physician payment sunshine act

Published:2018-10 Issue:3 Volume:54 Page:636-649
ISSN:0017-9124
Container-title:Health Services Research
language:en
Short-container-title:Health Serv Res

Author:

Brunt Christopher Scott¹^ORCID

Affiliation:

1. Department of EconomicsGeorgia Southern University Statesboro Georgia

Funder

Georgia Southern University

Publisher

Wiley

Subject

Health Policy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1475-6773.13064

Reference31 articles.

1. A National Survey of Physician–Industry Relationships

2. Physician Professionalism and Changes in Physician-Industry Relationships From 2004 to 2009

3. Understanding why GPs see pharmaceutical representatives: a qualitative interview study;Prosser H;Br J Gen Pract,2003

4. The effects and role of direct‐to‐physician marketing in the pharmaceutical industry: an integrative review;Manchanda P;Yale J Health Policy Law & Ethics,2005

5. Prescribers and Pharmaceutical Representatives: Why Are We Still Meeting?

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessing the impact of the Physician Payments Sunshine Act on pharmaceutical companies’ payments to physicians;PLOS ONE;2024-08-13

2. Pharmaceutical Industry Payments to Medical Oncologists in the Netherlands: Trends and Patterns Provided by an Open-Access Transparency Data Set;JCO Oncology Practice;2024-06

3. Pharmaceutical industry payments to NHS trusts in England: A four-year analysis of the Disclosure UK database;PLOS ONE;2023-11-01

4. Pharmaceutical industry payments and delivery of non-recommended and low value cancer drugs: population based cohort study;BMJ;2023-10-25

5. Changes in industry marketing payments to physicians during the covid-19 pandemic: quasi experimental, difference-in-difference study;BMJ Medicine;2022-09